Brief: Labcorp Completes Acquisition Of Select Assets Of BioReference Health's Innovative Oncology And Related Clinical Testing Services Businesses
15/09/2025 13:45
Sept 15 (Reuters) - Labcorp Holdings Inc LH.N: LABCORP COMPLETES ACQUISITION OF SELECT ASSETS OF BIOREFERENCE HEALTH'S INNOVATIVE ONCOLOGY AND RELATED CLINICAL TESTING SERVICES BUSINESSES LABCORP: PURCHASE PRICE FOR TRANSACTION IS UP TO $225 MILLION Source text: ID:nPn6v7yQfa Further company coverage: LH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Labcorp Declares Quarterly Dividend
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
Live Markets: Split US congress after 2026 midterms could boost healthcare stocks, Mizuho says
Deals of the day-Mergers and acquisitions